Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the interest coverage ratio high or low?
The interest coverage ratio of -4277.11x is 412% below its 5-year average of -835.05x, near the high end of its 5-year range (-240956.75x–-13.63x).
As of the fiscal period ended Thursday, December 31, 2020.
Reported quarterly interest coverage; no daily interpolation. Q4 FY2020 (2020-12-31): -4277.11x.
INTEREST COVERAGE RATIO
-4277.11x
INTEREST COVERAGE RATIO AVG TTM
N/A
INTEREST COVERAGE RATIO AVG 3Y
-44722.60x
INTEREST COVERAGE RATIO AVG 5Y
-835.05x
INTEREST COVERAGE RATIO AVG 10Y
-101.50x
INTEREST COVERAGE RATIO AVG 15Y
N/A
INTEREST COVERAGE RATIO AVG 20Y
N/A
CURRENT VS TTM AVG
N/A
CURRENT VS 3Y AVG
+90.44%
CURRENT VS 5Y AVG
-412.20%
CURRENT VS 10Y AVG
-4113.75%
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
-6.22x
median of 506 covered companies
CURRENT VS SECTOR MEDIAN
-68608.59%
vs the sector median at left
Cardiff Oncology, Inc.
Market Cap
$81.70M
Interest Coverage Ratio
-4277.11x
TTM Avg
N/A
3Y Avg
-44722.60x
5Y Avg
-835.05x
Market Cap
$81.96M
Interest Coverage Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$80.90M
Interest Coverage Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$82.53M
Interest Coverage Ratio
N/A
TTM Avg
2.82x
3Y Avg
2.82x
5Y Avg
2.82x
Market Cap
$80.23M
Interest Coverage Ratio
-369.11x
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$79.96M
Interest Coverage Ratio
-107.89x
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
| NAME | MARKET CAP | INTEREST COVERAGE RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Cardiff Oncology, Inc. (CRDF) | $81.70M | -4277.11x | N/A | -44722.60x | -835.05x |
| ProMIS Neurosciences, Inc. (PMN)vs › | $81.96M | N/A | N/A | N/A | N/A |
| MediciNova, Inc. (MNOV)vs › | $81.22M | N/A | N/A | N/A | N/A |
| Acrivon Therapeutics, Inc. Common Stock (ACRV)vs › | $80.90M | N/A | N/A | N/A | N/A |
| Telomir Pharmaceuticals, Inc. Common Stock (TELO)vs › | $82.53M | N/A | 2.82x | 2.82x | 2.82x |
| LENSAR Inc (LNSR)vs › | $83.02M | N/A | N/A | N/A | N/A |
| Nutriband Inc. (NTRB)vs › | $80.23M | -369.11x | N/A | N/A | N/A |
| Citius Oncology, Inc. (CTOR)vs › | $79.96M | -107.89x | N/A | N/A | N/A |
| Humacyte, Inc. (HUMA)vs › | $84.00M | -9.55x | N/A | N/A | N/A |
| Cognition Therapeutics, Inc. (CGTX)vs › | $84.15M | -3676.85x | N/A | N/A | N/A |
Interest Coverage
-4277.1x
Debt/Equity
0.02
Current Ratio
3.30
Formula: Interest Coverage = EBIT / Interest Expense
Reference ranges:
Note: Interest coverage should be compared with historical interest expense, operating income, and industry capital structure.
Interest Coverage = EBIT / Interest Expense
The interest coverage ratio measures operating earnings relative to interest expense.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | INTEREST COVERAGE RATIO |
|---|---|
| 2020-12-31 | -4277.11x |
| 2018-12-31 | -17689.66x |
| 2018-09-30 | -240956.75x |
| 2018-06-30 | -4799.56x |
| 2018-03-31 | -192.07x |
| 2017-12-31 | -420.44x |
| 2017-09-30 | -156.17x |
| 2017-06-30 | -13.63x |
| 2017-03-31 | -23.58x |
| 2016-12-31 | -23.98x |
| 2016-09-30 | -27.96x |
| 2016-06-30 | -36.30x |
| 2016-03-31 | -30.98x |
| 2015-12-31 | -18.82x |
| 2015-09-30 | -18.17x |
| 2015-06-30 | -16.96x |
| 2015-03-31 | -12.44x |
| 2014-12-31 | -11.61x |
| 2014-09-30 | -10.11x |
| 2014-06-30 | -59.25x |
| 2014-03-31 | -343.26x |
| 2013-12-31 | -282.80x |
| 2013-09-30 | -491.40x |
| 2013-06-30 | -3554.06x |
| 2011-06-30 | -23.02x |
| 2011-03-31 | -25.25x |
| 2010-12-31 | 5.13x |
| 2010-09-30 | 9.53x |
| 2010-06-30 | -4.06x |
| 2010-03-31 | -2.42x |
